title: Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).
authors: Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia, aurer@mef.hr.
authors: Igor
authors: I
authors: Aurer
authors: Sandra
authors: S
authors: Bašić-Kinda
authors: Ivo
authors: I
authors: Radman
authors: Ivana
authors: I
authors: Ilić
authors: Josip Joachim
authors: JJ
authors: Grah
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy; D008297:Male; D009102:Multiple Organ Failure / Q000209:etiology; D011241:Prednisone / Q000008:administration & dosage; D017211:Treatment Failure; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone